| 10280198 |
Therapeutic agents for reducing parathyroid hormone levels |
Amos Baruch, Derek Maclean, Kanad Das, Qun Yin |
2019-05-07 |
| 9701712 |
Therapeutic agents for reducing parathyroid hormone levels |
Amos Baruch, Derek Maclean, Kanad Das, Qun Yin |
2017-07-11 |
| 9567370 |
Therapeutic agents for reducing parathyroid hormone levels |
Amos Baruch, Derek Maclean, Kanad Das, Qun Yin |
2017-02-14 |
| 9278995 |
Therapeutic agents for reducing parathyroid hormone levels |
Amos Baruch, Derek Maclean, Kanad Das, Qun Yin |
2016-03-08 |
| 8999932 |
Therapeutic agents for reducing parathyroid hormone levels |
Amos Baruch, Derek Maclean, Kanad Das, Qun Yin |
2015-04-07 |
| 8987200 |
Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
Gregory Bell, Sarah Walter |
2015-03-24 |
| 8969299 |
Therapeutic agents for regulating serum phosphorus |
Gregory Bell |
2015-03-03 |
| 8377880 |
Therapeutic agents for reducing parathyroid hormone levels |
Amos Baruch, Derek Maclean, Kanad Das, Qun Yin |
2013-02-19 |
| 8105785 |
Mylks as modifiers of branching morphogenesis and methods of use |
Gregory D. Plowman, Candace Swimmer, Hinrich Alexander Habeck, Thomas I. Koblizek, Stefan Schulte-Merker +10 more |
2012-01-31 |
| 6531644 |
Methods for identifying anti-cancer drug targets |
Geoffrey Duyk, Casey Kopczynski, Jenny Kopczynski |
2003-03-11 |
| 6489127 |
Methods for identifying anti-cancer drug targets |
Geoffrey Duyk |
2002-12-03 |
| 5747275 |
Protein kinase required for RAS signal transduction |
Gerry Rubin, Marc Therrien, Henry Ping Chang, David Wassarman |
1998-05-05 |
| 5747288 |
Protein kinase required for Ras signal transduction |
Gerry Rubin, Marc Therrien, Henry Ping Chang, David Wassarman |
1998-05-05 |
| 5700675 |
Protein kinase required for Ras signal transduction |
Gerry Rubin, Marc Therrien, Henry Ping Chang, David Wassarman |
1997-12-23 |
